FindTrial
Sign In

The effect of patient education on compliance with drug therapy for rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN68585617
Enrollment
Unknown
Registered
2002-07-30
Start date
1993-01-12
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis Musculoskeletal Diseases Other rheumatoid arthritis

Interventions

Experimental group received a patient education programme

Sponsors

Arthritis Research Campaign (ARC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients deemed by the consultant rheumatologist to require dPenicillamine (DPA) as their disease modifying anti-rheumatic drug (DMARD) 2. Over 18 years of age 3. Plasma Viscosity (PV) =1.75 4. Cysteine rich protein (CRP) =10 5. Articular index 15 or less than 6. Morning stiffness =45 min 7. Pain level moderate/severe

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
It is anticipated that effective education will enhance compliance leading to better drug utilisation and improved patient outcome.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026